Clinical Trials
5 trialsNCT04161248 2026-05-12
Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
Canadian Cancer Trials Group
Phase EARLY_PHASE1 Active not recruiting
NCT06705530 2026-02-09
A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders
National Research Center for Hematology, Russia
Phase 1/2 Completed
NCT05784415 2026-02-02
CS22-03
AIDS Malignancy Consortium
Completed
NCT06721598 2024-12-06
An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders
National Research Center for Hematology, Russia
Not yet recruiting
NCT02847130 2023-07-19
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Children's Oncology Group
Completed